Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025)

Historic FCF Margin for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 341.17%.

  • Autolus Therapeutics' FCF Margin changed N/A to 341.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 557.85%, marking a year-over-year increase of 14778900.0%. This contributed to the annual value of 2256.38% for FY2024, which is 69646400.0% up from last year.
  • As of Q3 2025, Autolus Therapeutics' FCF Margin stood at 341.17%.
  • In the past 5 years, Autolus Therapeutics' FCF Margin ranged from a high of 341.17% in Q3 2025 and a low of 13088135.59% during Q3 2021
  • In the last 5 years, Autolus Therapeutics' FCF Margin had a median value of 2745.29% in 2023 and averaged 1109109.2%.
  • Per our database at Business Quant, Autolus Therapeutics' FCF Margin plummeted by 2000000000bps in 2021 and then skyrocketed by 2000000000bps in 2022.
  • Over the past 5 years, Autolus Therapeutics' FCF Margin (Quarter) stood at 13088135.59% in 2021, then surged by 100bps to 415.39% in 2022, then tumbled by -2372bps to 10267.49% in 2023, then tumbled by -1547bps to 169124.14% in 2024, then soared by 100bps to 341.17% in 2025.
  • Its last three reported values are 341.17% in Q3 2025, 382.63% for Q2 2025, and 933.07% during Q1 2025.